This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Eli Lilly and Company. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 987 
1 out of 4,517 
Years Active: 2025
Title: Xavier A Ortiz-Medina: Innovator in Pharmaceutical Synthesis
Introduction
Xavier A Ortiz-Medina is a notable inventor based in Noblesville, IN (US). He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of innovative processes for drug manufacturing. His work has implications for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.
Latest Patents
Xavier A Ortiz-Medina holds 1 patent for a process to make GLP1 RA and intermediates therefor. This patent relates to the synthesis of a complex compound, specifically 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo [4,3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, along with related synthetic intermediate compounds. This invention represents a significant advancement in the synthesis of therapeutic agents.
Career Highlights
Throughout his career, Ortiz-Medina has worked with prominent companies in the pharmaceutical industry. He has been associated with Eli Lilly and Company, a leading global healthcare company, and Chugai Seiyaku Kabushiki Kaisha, known for its innovative drug development. His experience in these organizations has contributed to his expertise in pharmaceutical synthesis.
Collaborations
Xavier A Ortiz-Medina has collaborated with notable professionals in his field, including Ayman D Allian and Kenneth Derek Berglund. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in drug synthesis.
Conclusion
Xavier A Ortiz-Medina is a distinguished inventor whose work in pharmaceutical synthesis has made a significant impact on the industry. His patent for the synthesis of GLP1 RA and intermediates demonstrates his commitment to advancing healthcare through innovation. His collaborations and career experiences further highlight
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile